Navigation Links
Insmed Announces First Quarter 2011 Financial Results
Date:5/10/2011

MONMOUTH JUNCTION, N.J., May 10, 2011 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company, today reported results for the first quarter ended March 31, 2011.

Key Recent Highlights:

  • Received Food and Drug Administration (FDA) clearance of Investigational New Drug (IND) Application to conduct a primary efficacy study for ARIKACE® (liposomal amikacin for inhalation) in non-tuberculous mycobacterial (NTM) lung disease
  • Filed for orphan drug status with FDA for ARIKACE® to treat NTM lung infections
  • Received acceptance of abstract for oral presentation of six cycles of data from the open-label study of ARIKACE® in the treatment of cystic fibrosis (CF) patients with Pseudomonas lung infections, at the European Cystic Fibrosis Conference in Hamburg, Germany in June
  • Executed a one-for-10 reverse stock split and regained compliance with Nasdaq's minimum bid price rule
  • Relocated corporate headquarters from Richmond, VA to Monmouth Junction, NJ

  • "The first several months of the year have produced multiple successes for Insmed," said Timothy Whitten, Insmed's President and CEO.  "In particular, we have reached several key milestones related to our development plan for ARIKACE®, including, most recently, the clearance of ARIKACE® to proceed to a primary efficacy study based on our NTM IND filing, and the submission in the U.S. of the ARIKACE® NTM orphan drug designation.  We continue to ramp up our ARIKACE® clinical trial and drug manufacturing activity and remain on schedule to begin enrollment of our Phase 3 clinical trials for ARIKACE® in patients who have NTM lung infections and in CF patients who have Pseudomonas lung infections, in the second half of this year.  In addition, we have regained compliance with Nasdaq's minimum bid price rule and we remain on solid financial ground, with a strong overall cash bala
    '/>"/>

    SOURCE Insmed Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Insmed to Host 2011 First Quarter Earnings Conference Call
    2. Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
    3. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
    4. Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split
    5. Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call
    6. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
    7. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
    8. Insmed to Host Third Quarter 2010 Conference Call
    9. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
    10. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
    11. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... , Switzerland , September ... receiving ISO 13485 accreditation, Sophia Genetics has become the ... clinical use of a Next Generation Sequencing (NGS) ... certification represents an important step in raising the ... and brings Sophia Genetics, world-leading Data Driven Medicine ...
    (Date:9/2/2014)... Calif. , Sept. 2, 2014 Redspin, ... and penetration testing services, today released an IT security ... "Today,s healthcare CEOs are presiding over the ... said Daniel W. Berger , Redspin,s President and ... CEO,s and their Boards of Directors understand why they ...
    (Date:9/2/2014)... , September 2, 2014 ... Drugs Market - Global Industry Analysis, Size, Share, ... to grow at a CAGR of 10.1% from 2014 ... from living cells and are used in the treatment ... diseases, auto-immune diseases and other medical disorders. Biological drugs ...
    Breaking Medicine Technology:Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 2CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 3CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 5CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 6
    ... Data presented today,at the Annual Congress of ... oral Factor Xa inhibitor DU-176b reduced the incidence,of ... elective unilateral hip replacement surgery. There was a,statistically ... the,observed bleeding rates were low across the groups. ...
    ... Bypass Surgery for Safety and ... Condition, WASHINGTON, Sept. 1 Patients with both ... will find good news in,new findings announced today from ... Interventions (SCAI). The one-year findings,of the new study indicate ...
    Cached Medicine Technology:Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI 2SCAI: CARDia Data Find Diabetic Patients With Complex Heart Disease Can Safely Choose PCI 3
    (Date:9/2/2014)... B. E. Smith, the only full-service leadership solutions ... to lead a national chief executive officer ... Sioux Falls, S.D. The top executive search firm in ... more than 900 healthcare executives into organizations. , ... and nationally recognized leader in patient-centered care. It is ...
    (Date:9/2/2014)... With thoughts of getting the kids ready to ... Washingtonians, it’s easy to forget that this is prime ... be booking their organizations’ holiday parties throughout the Washington, ... locations are preparing for the holiday rush. , “While ... the space appears to be going faster this year,” ...
    (Date:9/2/2014)... At the world-famous Magic Castle in Hollywood, California, famed ... being the first and only female staff Medium. Throughout the ... female magician to hold such a position. , “I’m deeply ... says Misty Lee. “Even since I was a child, magic ... can fascinate guests in much the same way.” , At ...
    (Date:9/2/2014)... 02, 2014 “Is there an ultimate ... that millions of people ask. Diagnosing and curing scabies ... and their families or treatment partners. The diagnostic challenge ... distinct similarities to other skin conditions such as: papular ... eczema, varicella and many others. Scabies is also ...
    (Date:9/2/2014)... 02, 2014 On August 22 and ... Associates in Duluth, GA and Precious Hearing Inc. in ... team at the 2014 National Basketball Retired Players Association ... While interacting with the former players and their families ... team provided free hearing screenings, video ear inspections, and ...
    Breaking Medicine News(10 mins):Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Sioux Falls Specialty Hospital Retains B. E. Smith to Recruit New CEO 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 4Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 5Health News:Magician Misty Lee is the First and Only Female Staff Medium at Hollywood’s Magic Castle 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 4Health News:The EarQ Team Brings Hearing Health Awareness to the 2014 National Basketball Retired Players Association Annual Convention in Cancun 2
    ... population increases, so does its need for long-term care. And ... they need particularly in the area of pay and ... Research on the Long-Term Care Workforce," the latest special ... Special Issue 1). , Those aged 65 and older are ...
    ... to settle question about best treatment for the disease ... update from a European study that has followed men ... the debate about the advantages of aggressive treatment versus ... for men who underwent surgery to remove the prostate ...
    ... today launched an online campaign (http://www.votekids08.org ) ... the importance of investing in the,key building blocks ... issues must be a priority for all Presidential ... have,adequate health care, quality early care and education, ...
    ... 12 Online Internet,shopping today offers many benefits. You ... home and purchase most anything by clicking a mouse.,But ... the Internet,bypassing a traditional office visit or conversation with ... researchers from Utah and,several colleagues compare the relative safety ...
    ... Esoteric,Laboratory Institute Main Laboratory, Van Nuys, California, has ... Accreditation of,the College of American Pathologists (CAP), based ... PathNet,s Laboratory Director, Juan Felix, MD, was advised ... of the services,being provided." PathNet Esoteric Lab Institute ...
    ... cancer onto a sucker punch by getting infected cells to ... are using the metal ruthenium as a catalyst to a ... oxidants as an ally. , Cancer adapts quickly to ... laboratory tests reveal a second line of defence using ruthenium ...
    Cached Medicine News:Health News:Long-term care workers struggle with elderly population boom 2Health News:Surgery Helps With Prostate Cancer, Sometimes 2Health News:Surgery Helps With Prostate Cancer, Sometimes 3Health News:VOICES Launches 'Vote Kids 2008' to Engage Voters and Candidates in Shaping National Policies for America's Children 2Health News:Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications 2Health News:Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications 3Health News:PathNet Esoteric Laboratory Institute Main Laboratory Receives Accreditation From College of American Pathologists 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: